News & Updates

MTN studies reflect acceptability, safety of dapivirine vaginal ring for HIV prevention

12 Aug 2021 by

The monthly dapivirine vaginal ring (DVR), which has been found to reduce HIV risk with no safety issues, continues to show its potential as an acceptable and safe preventive method against HIV, according to data from several phase III MTN* studies presented at IAS 2021.

MTN studies reflect acceptability, safety of dapivirine vaginal ring for HIV prevention

12 Aug 2021

Depression no longer a barrier to DAA initiation for patients with HIV-HCV

12 Aug 2021 by

Despite having depressive symptoms, treatment initiation rates seem to be improving among patients coinfected with HIV and hepatitis C virus (HCV), according to a study presented at the recently concluded 2021 International AIDS Society Conference on HIV Science (IAS 2021).

Depression no longer a barrier to DAA initiation for patients with HIV-HCV

12 Aug 2021

Shorter DAPT durations provide best balance between efficacy, safety

12 Aug 2021

Short-term (≤6 months) and shorter durations (≤3 months) of dual antiplatelet therapy (DAPT) reduce the risk of bleeding and are equally effective, with a trend towards lower all-cause mortality independent of coronary artery disease stability, according to the results of a meta-analysis.

Shorter DAPT durations provide best balance between efficacy, safety

12 Aug 2021

Chimeric antigen receptor T-cell immunotherapy after ASCT effective against CNS lymphoma

12 Aug 2021

Sequential treatment with CD22/19 chimeric antigen receptor (CAR) T-cell immunotherapy after autologous stem cell transplantation (ASCT) seems to have long-term efficacy against central nervous system lymphoma (CNSL), a recent study has found.

Chimeric antigen receptor T-cell immunotherapy after ASCT effective against CNS lymphoma

12 Aug 2021

Oral nutrition supplements do not minimize weight loss postgastrectomy

12 Aug 2021

For patients who have undergone gastrectomy, use of oral nutrition supplements (ONS) for 12 weeks falls short of preventing further weight loss, according to a study. However, the weight lost over 1 year after surgery appears to be lower among those who took more than 200 kcal/day of the said supplements.

Oral nutrition supplements do not minimize weight loss postgastrectomy

12 Aug 2021

mRNA COVID-19 vaccine in patients on cancer treatment: Is response durable?

12 Aug 2021 by

Anti-spike (anti-S) immunoglobulin G (IgG) antibody seropositivity rate in patients on active anticancer treatment remains high approximately 4 months after the second dose of the BNT162b2 mRNA coronavirus disease 2019 (COVID-19) vaccine, although median IgG titres are significantly lower than those in healthy individuals, a recent study has shown.

mRNA COVID-19 vaccine in patients on cancer treatment: Is response durable?

12 Aug 2021

Fixed-duration first-line ibrutinib-venetoclax improves PFS over chlorambucil-obinutuzumab for CLL

11 Aug 2021 by

Fixed-duration ibrutinib plus venetoclax (I+V) significantly improved progression-free survival (PFS) over chlorambucil plus obinutuzumab (Clb+O) in the first-line treatment of patients with chronic lymphocytic leukaemia (CLL), primary results of the phase III GLOW trial showed.

Fixed-duration first-line ibrutinib-venetoclax improves PFS over chlorambucil-obinutuzumab for CLL

11 Aug 2021

Maintaining a social network keeps the brain healthy

11 Aug 2021

In older adults, social engagement helps protect against cognitive decline or dementia in later life, particularly in men, a recent Korea study has found.

Maintaining a social network keeps the brain healthy

11 Aug 2021

Feminizing hormone therapy does not nix oral pre-exposure prophylaxis

11 Aug 2021 by

Use of feminizing hormone therapy (FHT) does not appear to cancel the effect of oral pre-exposure prophylaxis (PrEP) in transgender women at high risk of HIV, according to data from the PrEParadas study presented at the 11th International AIDS Society Conference (IAS 2021).

Feminizing hormone therapy does not nix oral pre-exposure prophylaxis

11 Aug 2021

Adherence to TKI regimen very high among NSCLC patients

11 Aug 2021

Nonsmall cell lung cancer (NSCLS) patients show exceptionally high adherence to tyrosine kinase inhibitors (TKIs), results of a recent study have shown. This supports the effectiveness of TKI therapy and a good quality of life over a long period of time.

Adherence to TKI regimen very high among NSCLC patients

11 Aug 2021

News & Updates

Filter by Specialty:

Specialty:

MTN studies reflect acceptability, safety of dapivirine vaginal ring for HIV prevention

MTN studies reflect acceptability, safety of dapivirine vaginal ring for HIV prevention

Depression no longer a barrier to DAA initiation for patients with HIV-HCV

Depression no longer a barrier to DAA initiation for patients with HIV-HCV

Shorter DAPT durations provide best balance between efficacy, safety

Shorter DAPT durations provide best balance between efficacy, safety

Chimeric antigen receptor T-cell immunotherapy after ASCT effective against CNS lymphoma

Chimeric antigen receptor T-cell immunotherapy after ASCT effective against CNS lymphoma

Oral nutrition supplements do not minimize weight loss postgastrectomy

Oral nutrition supplements do not minimize weight loss postgastrectomy

mRNA COVID-19 vaccine in patients on cancer treatment: Is response durable?

mRNA COVID-19 vaccine in patients on cancer treatment: Is response durable?

Fixed-duration first-line ibrutinib-venetoclax improves PFS over chlorambucil-obinutuzumab for CLL

Fixed-duration first-line ibrutinib-venetoclax improves PFS over chlorambucil-obinutuzumab for CLL

Maintaining a social network keeps the brain healthy

Maintaining a social network keeps the brain healthy

Feminizing hormone therapy does not nix oral pre-exposure prophylaxis

Feminizing hormone therapy does not nix oral pre-exposure prophylaxis

Adherence to TKI regimen very high among NSCLC patients

Adherence to TKI regimen very high among NSCLC patients